HistoSonics

Plymouth, MN · Founded 2009 · Privately Held (backing)

Developer of a non-invasive and robotically assisted ultrasound therapy device designed for precise tissue destruction. HistoSonics is based in Plymouth, MN and was founded in 2009. It was valued at $610 million at its later-stage round in Aug 2024, the last priced event on record. It has raised $250 million across 3 recorded rounds; the latest was a $102 million later-stage round in Jul 2024.

PMV mark · valuation
$610.0M
Oct 2026
Priced at
its later-stage round
Aug 2024
Total raised
$250.0M
Last round
Later Stage VC
Jul 2024
What is HistoSonics worth?
$610.0MPrivateMarketView mark · Oct 2026

Valued at $610.0M at its later-stage round, Aug 2024. Nothing has traded since.

Free account
More of HistoSonics with a free account
  • ·The complete investor list: 16 names
  • ·Watch HistoSonics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

HistoSonics funding history

3 rounds
DateRoundRaisedPost-money
Jul 2024Later Stage VC$102.0M▮
Dec 2022Debt$85.0M▮
Apr 2020Early Stage VC$40.8M▮
Unlock post-money valuations

Membership and data by Private Market View

HistoSonics valuation

HistoSonics was valued at $610 million at its later-stage round in Aug 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has HistoSonics raised?

HistoSonics has raised $250 million across 3 recorded rounds since 2020. The largest was an $85 million debt round in Dec 2022; the most recent was a $102 million later-stage round in Jul 2024.

HistoSonics has filed 4 Form Ds with the SEC since 2020, most recently in Aug 2024 ($102 million sold to 39 investors).

How HistoSonics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For HistoSonics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about HistoSonics

What is HistoSonics worth?
HistoSonics is valued at $610.0M as of Oct 2026. Valued at $610.0M at its later-stage round, Aug 2024. Nothing has traded since.
How much has HistoSonics raised?
HistoSonics has raised $250.0M in total funding across 3 recorded rounds.
When did HistoSonics last raise?
HistoSonics last raised in Jul 2024 (Later Stage VC), raising $102.0M.